Import Ceraeye Synthetic Hydroxyapatite Orbital Implant — Buy in Bulk from Supplier in India

The Ceraeye synthetic hydroxyapatite orbital implant is a biocompatible medical device designed for orbital reconstruction following trauma, disease, or enucleation. It is manufactured from 100% synthetic hydroxyapatite, a calcium phosphate ceramic that mimics the mineral composition of natural bone, ensuring seamless integration with surrounding tissues. The implant’s porous structure promotes vascularisation and fibrovascular ingrowth, reducing the risk of migration or extrusion.

Hydroxyapatite implants like this are typically supplied in standard spherical or custom-milled shapes to fit the orbital cavity, with a density of approximately 3.15 g/cm³ and a compressive strength exceeding 500 MPa. The material is inert, non-toxic, and free from animal-derived components, making it suitable for patients with allergies or ethical restrictions. Industry-standard hydroxyapatite implants are often gamma-sterilised and packaged in double-peel pouches to maintain asepsis.

This implant is primarily used by ophthalmic surgeons in hospitals and specialised eye care centres for post-enucleation socket reconstruction or trauma repair. Buyers typically include medical distributors, surgical supply chains, and government tenders for public health systems. Trade terms such as MOQ, incoterms, and lead times are supplier-specific and should be confirmed directly with IFGL Bioceramics Ltd., as these are not disclosed in the current listing.

IFGL Bioceramics Ltd. is based in Kolkata, West Bengal, India, operating from Mcleod House 3 on Netaji Subhas Road. The company specialises in advanced bioceramic materials for medical applications, with a focus on synthetic hydroxyapatite products for orthopaedic and ophthalmic use. As an importer-tier supplier, its profile indicates engagement in the distribution of high-specification medical devices, though no additional verification or response metrics are currently provided.

The supplier’s listing for the Ceraeye implant highlights its collaboration with Central Glass & Ceramic for material technology, but no further details about manufacturing scale, certifications beyond ISO and CE mentions in the source text, or client history are available. Buyers are advised to request updated compliance documentation, production capabilities, and quality control processes directly from IFGL Bioceramics Ltd. to assess suitability for their procurement needs.